Endo, other drugmakers sued over ‘pay-for-delay’ deals
( April 1, 2016) -- The Federal Trade Commission sued Endo Pharmaceuticals and several other drugmakers alleging that they used ‘pay-for-delay’ settlements to block consumers’ access to lower-cost generic versions of Opana ER and Lidoderm....